Zhongzhi Pharmaceutical Holdings Limited (3737.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 434.86M |
| Enterprise Value | 460.99M |
| P/E Ratio | 28.23 |
| PEG Ratio | -0.35 |
| Price/Sales Ratio | 0.28 |
| Price/Book Ratio | 0.45 |
| Enterprise/Revenue | 0.3 |
| Enterprise/EBITDA | 9.3 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
Profitability
| Profit Margin | 0.01 |
| Operating Margin | 0 |
AD
Management Effectiveness
| Return On Assets | 0.01 |
| Return On Equity | 0.02 |
Income Statement
| Revenue | 1.74B |
| Revenue/Share | 2.04 |
| Gross Profit | 940.25M |
| EBITDA | 55.28M |
| Net Income | 17.29M |
| Diluted EPS | 0.02 |
Balance Sheet
| Total Cash | 200.89M |
| Total Cash/Share | 0.28 |
| Total Debt | 227.02M |
| Total Debt/Equity | 0.21 |
| Current Ratio | 1.6 |
| Book Value Per Share | 1.29 |
Price History
| 52-Week Change | -20.24 |
| 52-Week High | 0.98 |
| 52-Week Low | 0.5 |
| Moving Average 50 Days | 0.79 |
| Moving Average 200 Days | 0.71 |
Statistics
| Average Volume | 434,915 |
| Shares Outstanding | 843.74M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.04 |
| Trailing Annual Dividend Yield | 7.46 |
| Payout Ratio | 2.27 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
